Cluster Headache Epidemiology Forecast 2026-2035

Cluster headache is a rare but severe neurological disorder characterized by unilateral trigeminal pain and autonomic symptoms. According to David Fernández-Hernando et al. (2023), its global prevalence is approximately 0.5-3 per 1,000 individuals, significantly impairing quality of life. According to the cluster headache epidemiology forecast, the condition remains underdiagnosed yet imposes a substantial clinical burden worldwide.

Cluster Headache Epidemiology Forecast Report Coverage

The analyst's “Cluster Headache Epidemiology Forecast Report 2026-2035” offers comprehensive information on the prevalence and demographics of cluster headache. It projects the future incidence and prevalence rates of cluster headache cases across various populations. The study covers age, gender, and type as major determinants of the cluster headache population. The report highlights patterns in the prevalence of cluster headache over time and projects future trends based on multiple variables.

The report provides a comprehensive overview of the disease, as well as historical and projected data on the epidemiology of cluster headache in the 8 major markets.

Regions Covered

• The United States
• Germany
• France
• Italy
• Spain
• The United Kingdom
• Japan
• India

Cluster Headache Understanding: Disease Overview

Cluster headache is a primary neurological disorder characterized by severe, unilateral head pain, typically centered around the eye or the temporal region. It occurs due to dysregulation of the hypothalamus and activation of the trigeminal-autonomic reflex, leading to cranial autonomic symptoms such as lacrimation, nasal congestion, and ptosis. Attacks are short but extremely intense, often occurring in cyclical patterns or “clusters.” The condition is classified into two main types: episodic cluster headache, with remission periods, and chronic cluster headache, where attacks persist for more than one year without significant remission.

Cluster Headache Epidemiology Perspective

The cluster headache epidemiology division offers information on the patient pool from history to the present as well as the projected trend for each of the 8 major markets. The analyst provides both current and predicted trends for the cluster headache epidemiology scenario by examining a wide range of studies. Additionally, the report covers the diagnosed patient pool for cluster headache and their trends. The data is broken down into specific categories, such as total prevalent cases in males and females, and total diagnosed cases across different age groups and patient pools.

• According to Daniel San-Juan et al., 2024, cluster headache affects approximately 0.1% of the population globally, with a mean prevalence of 53 per 100,000 (range 3-150 per 100,000), while Arne May et al., 2023 estimates prevalence to be between 0.1% and 0.2%.
• As per Daniel San-Juan et al., 2024, incidence ranges from 2.07 to 9.8 per 100,000 person-years. Despite low incidence, the disorder imposes a high burden, with nearly 80% of patients experiencing episodic forms characterized by recurrent daily attacks and remission periods.
• According to Leon S. Moskatel et al., 2025, and Merck & Co., Inc., onset typically occurs between 20 and 40 years of age, with peak prevalence between 20 and 50 years. The mean age of onset is approximately 30.2 ± 13.8 years.
• As per Arne May et al., 2023 and Daniel San-Juan et al., 2024, cluster headache shows a historical male predominance of 3-4:1, now revised to 1.3-2.6:1, indicating a narrowing gender gap and improved recognition in female patients.
• According to Arne May et al., 2023 and Merck & Co., Inc., cluster headache is not associated with significant mortality. However, delayed diagnosis and inadequate treatment contribute to substantial morbidity, frequent attacks, and impaired quality of life.

Country-wise Cluster Headache Epidemiology

The cluster headache epidemiology data and findings for the United States, Germany, Spain, Italy, France, the United Kingdom, Japan, and India are also provided in the epidemiology section.

Overall, the epidemiology of cluster headache across the covered regions reflects low prevalence with variability in diagnosis and reporting. According to Merck & Co., Inc., prevalence in the United States is approximately 0.1%, with a higher incidence in men and typical onset between 20 and 40 years of age. In France, as per E.K. Van Obberghen et al. (2026), the annual prevalence is estimated at 0.146%, corresponding to nearly 99,000 cases in 2024. In Japan and India, as per the Indian Medical Association, cluster headache remains underdiagnosed within the broader burden of headache disorders, highlighting gaps in epidemiological data and disease recognition across regions.

Cluster Headache: Treatment Overview

Cluster headache management focuses on rapid relief of acute attacks and prevention of recurrence. Acute treatments include high-flow oxygen therapy and fast-acting medications such as subcutaneous triptans (e.g., sumatriptan). Preventive therapy is essential during cluster periods and commonly involves calcium channel blockers such as verapamil. Other options include corticosteroids for transitional therapy, lithium for chronic cases, and newer calcitonin gene-related peptide (CGRP) inhibitors. In refractory cases, neuromodulation techniques such as occipital nerve stimulation may be considered to reduce attack frequency and severity.

Key Questions Answered

• What are the key findings of cluster headache epidemiology in the 8 major markets?
• What will be the total number of patients with cluster headache across the 8 major markets during the forecast period?
• What was the country-wise cluster headache epidemiology scenario in the 8 major markets in the historical period?
• Which country will have the highest number of cluster headache patients during the forecast period of 2026-2035?
• Which key factors would influence the shift in the patient population of cluster headache during the forecast period of 2026-2035?
• What are the currently available treatments for cluster headache?
• What are the disease risks, signs, symptoms, and unmet needs of cluster headache?

Scope of the Cluster Headache Epidemiology Report

• The report covers a detailed analysis of signs and symptoms, causes, risk factors, pathophysiology, diagnosis, treatment options, and classification/types of cluster headache based on several factors.
• Cluster Headache Epidemiology Forecast Report covers data for the eight major markets (the US, France, Germany, Italy, Spain, the UK, Japan, and India).
• The cluster headache report helps to identify the patient population, and the unmet needs are highlighted along with an assessment of the disease's risk and burden.